Clinical Trial Update: Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)

View source ↗

Summary

The ANCA-associated vasculitis immune tolerance trial sponsored by NIAID was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: ANCA-Associated Vasculitis | Status: TERMINATED | Results posted: 2016-05-20